Skip to search formSkip to main contentSkip to account menu

eprazinone

Known as: 3-(4-(beta-ethoxyphenethyl)-1-piperazinyl)-2-methylpropiophenone, 1-(2-phenyl-2-ethoxy)ethyl-4-(2-benzyloxy)propylpiperazine, Éprazinone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Neurokinin receptors (NKRs) have been shown to be involved in many physiological processes, rendering them promising novel drug… 
1992
1992
Eprazinone therapy improves pulmonary function and arterial pO2 in patients with chronic bronchitis; however, the mechanism of… 
1991
1991
The crystal structure of eprazinone dihydrochloride, 2HCl, has been determined from 2102 independent reflections collected on an… 
1985
1985
1984
1984
A drug eruption with subcorneal pustulation is presented, occurring in a patient during treatment with eprazinone . The biopsy of… 
1981
1981
After oral application of 3-[4-(beta-ethoxyphenethyl)-1-piperazinyl]-2-methylpropiophenone dihydrochloride (eprazinone, Eftapan… 
1980
1980
This study should demonstrate the efficiency of a new bronchosecretolytic substance, Eprazinone, in therapy of acute and chronic… 
1977
1977
Perry and Boyd's method described in 1941 appears to be the most suitable for evaluating the efficacy of expectorants. In this… 
1976
1976
The study of therapeutical agents for "mucolysis" enables a classification of these drugs from their mode of action at the…